What is the address of Algemene Geneeskunde en Consulting RVDN?

The registered office of Algemene Geneeskunde en Consulting RVDN is located at Molenstraat 19, 9550 Herzele.

Is Algemene Geneeskunde en Consulting RVDN still active?

Yes. According to the CBE (17 September 2026) Algemene Geneeskunde en Consulting RVDN is active, legal situation “Normale toestand”, started on 4 September 2024.

Is Algemene Geneeskunde en Consulting RVDN registered on Peppol?

Yes, Algemene Geneeskunde en Consulting RVDN is registered on the Peppol network with ID 0208:1013135009.

What is the enterprise number of Algemene Geneeskunde en Consulting RVDN?

The enterprise number of Algemene Geneeskunde en Consulting RVDN is BE1013135009.

When was Algemene Geneeskunde en Consulting RVDN founded?

Algemene Geneeskunde en Consulting RVDN was founded on 4 September 2024.

Who are the directors of Algemene Geneeskunde en Consulting RVDN?

According to the 2025 annual accounts, the directors of Algemene Geneeskunde en Consulting RVDN are: Rik Michel Van Den Neste.

Is Algemene Geneeskunde en Consulting RVDN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 September 2024; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Algemene Geneeskunde en Consulting RVDN make in 2025?

Algemene Geneeskunde en Consulting RVDN posted a profit after taxes of € 81,581 in financial year 2025.

What is the revenue of Algemene Geneeskunde en Consulting RVDN?

As a small company, Algemene Geneeskunde en Consulting RVDN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 103,988.

Algemene Geneeskunde en Consulting RVDN (Private Limited)

Dossier Algemene Geneeskunde en Consulting RVDN, printed on 17 September 2026 from databakkes.be/en/1013135009/algemene-geneeskunde-en-consulting-rvdn. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Algemene Geneeskunde en Consulting RVDN from Herzele, company number BE1013135009, closed financial year 2025 with a result of € 81,581 after tax. For that financial year Algemene Geneeskunde en Consulting RVDN recorded a gross margin of € 103,988 and equity of € 153,178. Compared with financial year 2024, the result moved from € 66,597 to € 81,581. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Growing

€ 153,178

▲ 114% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 81,581

▲ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 66,114

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 148,178.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,230

▲ € 1,709 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 192

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 88,816 Gross margin 2024: € 88,816 First fiscal year in the series	€ 103,988 Gross margin 2025: € 103,988 ▲ 17% vs 2024 (€ 88,816) Favourable step	▲ 17%
Profit after taxes	€ 66,597 Profit after taxes 2024: € 66,597 First fiscal year in the series	€ 81,581 Profit after taxes 2025: € 81,581 ▲ 22% vs 2024 (€ 66,597) Favourable step	▲ 22%
Equity	€ 71,597 Equity 2024: € 71,597 First fiscal year in the series	€ 153,178 Equity 2025: € 153,178 ▲ 114% vs 2024 (€ 71,597) Favourable step	▲ 114%
Total debts	€ 3,996 Total debts 2024: € 3,996 First fiscal year in the series	€ 3,819 Total debts 2025: € 3,819 ▼ 4% vs 2024 (€ 3,996) Favourable step	▼ 4%
Cash	€ 57,863 Cash 2024: € 57,863 First fiscal year in the series	€ 66,114 Cash 2025: € 66,114 ▲ 14% vs 2024 (€ 57,863) Favourable step	▲ 14%
Retained profit	€ 66,597 Retained profit 2024: € 66,597 First fiscal year in the series	€ 148,178 Retained profit 2025: € 148,178 ▲ 122% vs 2024 (€ 66,597) Favourable step	▲ 122%
Balance sheet total	€ 75,593 Balance sheet total 2024: € 75,593 First fiscal year in the series	€ 156,996 Balance sheet total 2025: € 156,996 ▲ 108% vs 2024 (€ 75,593) Unchanged	▲ 108%

Key figures of Algemene Geneeskunde en Consulting RVDN, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Algemene Geneeskunde en Consulting RVDN?

What happened at Algemene Geneeskunde en Consulting RVDN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2026 New annual accounts for financial year 2025: profit of € 81,581 (▲ 22% vs 2024). Source: NBB ↗
Sep 4, 2024 New establishment in Herzele. KBO
Sep 4, 2024 Start of the company according to the CBE. KBO

In short

From € 66,597 profit in 2024 to € 81,581 profit in 2025.

Paid € 45,099 in corporate taxes since 2024.

Best year ever: 2025, with € 81,581 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Algemene Geneeskunde en Consulting RVDN? We notify you, reason included.

Follow Algemene Geneeskunde en Consulting RVDN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Rik Michel Van Den Neste

Algemene Geneeskunde en Consulting RVDN

Behind Algemene Geneeskunde en Consulting RVDN is Rik Michel Van Den Neste.

See the full network in the app

Directors

According to the 2025 annual accounts

Rik Michel Van Den Neste

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Molenstraat 19

9550 Herzele

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 1013.135.009
VAT number: BE 1013.135.009
Registered office: Molenstraat 19, 9550 Herzele
Names & denominations: Algemene Geneeskunde en Consulting RVDN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 September 2024
Peppol: Active · Active since 17 Jun 2025

View on CBE Public ↗ Annual accounts (NBB) ↗